EBSEmergent BioSolutions Inc.vs its industry peers
A metric-by-metric comparison of Emergent BioSolutions Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBS본 종목 | $331M#4 | — | 1.0x#1 | 0.4x#1 | -28.8%#3 | 127.6%#1 | 13.5%#1 | 15.4%#1 | 8.1%#1 | 6#1 | -17.4%#3 | — |
| IRD | $372M#1 | — | — | 26.2x#2 | 29.1%#1 | 13.8%#2 | -271.9%#2 | — | — | — | 250.6%#1 | — |
| CATX | $354M#2 | — | 1.1x#2 | 247.2x#4 | — | -30.1%#3 | -7919.4%#4 | -31.8%#2 | -41.0%#2 | — | -8.9%#2 | — |
| UPB | $354M#3 | — | 1.3x#3 | 124.2x#3 | 20.4%#2 | -128.4%#4 | -5618.8%#3 | -52.9%#3 | — | — | -67.6%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice